Key neuropathological changes associated with late-onset dementia are not fully understood. Population-based longitudinal studies offer an opportunity to step back and examine which pathological indices best link to clinical state. CC75C is a longitudinal study of the population aged 75 and over at baseline in Cambridge, UK. We report on the first 213 participants coming to autopsy with sufficient information for an end of life dementia diagnosis. Clinical diagnosis was ascertained by examining retrospective informant interviews, survey responses, and death certificates according to DSM-IV criteria. The neuropathological protocol was based on the Consortium to Establish a Registry of Alzheimer's Disease (CERAD). Clinical dementia was presen...
Limbic-predominant age-related TDP-43 encephalopathy neuropathologic change (LATE-NC) and Alzheimer’...
OBJECTIVE: To examine the relative contributions of frailty and neuropathology to dementia expressio...
Dementia drug development aims to modulate pathological processes that cause clinical syndromes. Pop...
Key neuropathological changes associated with late-onset dementia are not fully understood. Populati...
Key neuropathological changes associated with late-onset dementia are not fully understood. Populati...
BACKGROUND: Research in Alzheimer's disease is focused mainly on younger old persons, whereas studie...
Population-based longitudinal clinicopathological studies provide an ideal opportunity to study a va...
Background: Dementia drug development aims to modulate pathological processes that cause clinical sy...
Objective: Although it is now widely accepted that dementia has a long preclinical phase during whic...
IntroductionThe association between neuropathological changes and dementia among centenarians and no...
With aging, the incidence of neuropathological hallmarks of neurodegenerative diseases increases in ...
ObjectiveOur objectives were to characterize the inter-relation of known dementia-related neuropatho...
The association of dementia-related pathologies with cognition is hypothesized to decrease as age ad...
The state between aging with no cognitive impairment and dementia has become a major focus for inter...
ObjectiveTo examine whether the association between clinical Alzheimer disease (AD) diagnosis and ne...
Limbic-predominant age-related TDP-43 encephalopathy neuropathologic change (LATE-NC) and Alzheimer’...
OBJECTIVE: To examine the relative contributions of frailty and neuropathology to dementia expressio...
Dementia drug development aims to modulate pathological processes that cause clinical syndromes. Pop...
Key neuropathological changes associated with late-onset dementia are not fully understood. Populati...
Key neuropathological changes associated with late-onset dementia are not fully understood. Populati...
BACKGROUND: Research in Alzheimer's disease is focused mainly on younger old persons, whereas studie...
Population-based longitudinal clinicopathological studies provide an ideal opportunity to study a va...
Background: Dementia drug development aims to modulate pathological processes that cause clinical sy...
Objective: Although it is now widely accepted that dementia has a long preclinical phase during whic...
IntroductionThe association between neuropathological changes and dementia among centenarians and no...
With aging, the incidence of neuropathological hallmarks of neurodegenerative diseases increases in ...
ObjectiveOur objectives were to characterize the inter-relation of known dementia-related neuropatho...
The association of dementia-related pathologies with cognition is hypothesized to decrease as age ad...
The state between aging with no cognitive impairment and dementia has become a major focus for inter...
ObjectiveTo examine whether the association between clinical Alzheimer disease (AD) diagnosis and ne...
Limbic-predominant age-related TDP-43 encephalopathy neuropathologic change (LATE-NC) and Alzheimer’...
OBJECTIVE: To examine the relative contributions of frailty and neuropathology to dementia expressio...
Dementia drug development aims to modulate pathological processes that cause clinical syndromes. Pop...